Advertisement
Screener

Aurinia Pharmaceuticals Inc. (AUPH) Net Margin

Aurinia Pharmaceuticals Inc. (AUPH) Net Margin

  • 2026-06-30: Net Margin 44.96%.
  • 2026-03-31: Net Margin 44.21%.
  • 2025-12-31: Net Margin 273.35%.
  • 2025-09-30: Net Margin 42.95%.

Complete source-backed net margin history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-3044.96%
2026-03-3144.21%
2025-12-31273.35%
2025-09-3042.95%
2025-06-3030.73%
2025-03-3137.37%
2024-12-312.39%
2024-09-3021.17%
2024-06-301.26%
2024-03-31-21.37%
2023-12-31-59.60%
2023-09-30-24.67%
2023-06-30-27.70%
2023-03-31-76.16%
2022-12-31-91.60%
2022-09-30-16.12%
2022-06-30-125.98%
2022-03-31-174.01%
2021-12-31-142.38%
2021-09-30-342.64%
2021-06-30-710.12%
2021-03-31-5511.93%
2020-12-31-16.14%
2020-09-30-145275.86%
2020-06-30-91531.03%
2020-03-31-86440.00%

Annual Net Margin

DateNet Margin
2025-12-31101.47%
2024-12-312.45%
2023-12-31-44.45%
2022-12-31-80.71%
2021-12-31-396.81%
2020-12-31-204.88%
2019-12-31-27794.03%
2018-12-31-11464.15%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Zai Lab Ltd (ZLAB)$2.241B-113.34
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Generate Biomedicines, Inc. (GENB)United States$2.052B